Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells.
Saved in:
| Title: | Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells. |
|---|---|
| Authors: | Amaro, Adriana1 (AUTHOR), Reggiani, Francesco1 (AUTHOR), Fenoglio, Daniela1,2 (AUTHOR), Gangemi, Rosaria1 (AUTHOR), Tosi, Anna3 (AUTHOR), Parodi, Alessia1 (AUTHOR), Banelli, Barbara1 (AUTHOR), Rigo, Valentina1 (AUTHOR), Mastracci, Luca1 (AUTHOR), Grillo, Federica1 (AUTHOR), Cereghetti, Alessandra4 (AUTHOR), Tastanova, Aizhan4 (AUTHOR), Ghosh, Adhideb5 (AUTHOR), Sallustio, Fabio6 (AUTHOR), Emionite, Laura1 (AUTHOR), Daga, Antonio1 (AUTHOR), Altosole, Tiziana1 (AUTHOR), Filaci, Gilberto1,2 (AUTHOR), Rosato, Antonio3,7 (AUTHOR), Levesque, Mitchell4 (AUTHOR) |
| Source: | Journal of Experimental & Clinical Cancer Research (17569966). 3/18/2023, Vol. 42 Issue 1, p1-24. 24p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17569966 |
|---|---|
| DOI: | 10.1186/s13046-023-02628-x |
